A
Anna Santacruz
Researcher at Washington University in St. Louis
Publications - 16
Citations - 4528
Anna Santacruz is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Gantenerumab & Solanezumab. The author has an hindex of 10, co-authored 15 publications receiving 3488 citations.
Papers
More filters
Journal ArticleDOI
Erratum to “Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial” [Rev. Neurol. 169 (10) (2013) 737–743]
SM Mills,J. Mallmann,Anna Santacruz,A. Fuqua,M. Carril,P. S. Aisen,M. C. Althage,S. Belyew,Tammie L.S. Benzinger,William S. Brooks,Virginia Buckles,Nigel J. Cairns,David B. Clifford,A Danek,Anne M. Fagan,M. Farlow,Nick C. Fox,Bernardino Ghetti,A. Goate,D. Heinrichs,Russ C. Hornbeck,C. Jack,Mathias Jucker,William E. Klunk,Daniel S. Marcus,Ralph N. Martins,C. M. Masters,Richard P. Mayeux,Eric McDade,John C. Morris,Angela Oliver,John M. Ringman,Martin N. Rossor,Stephen Salloway,Peter R. Schofield,J Snider,P. Snyder,Reisa A. Sperling,C Stewart,Ronald G. Thomas,Chengjie Xiong,Randall J. Bateman +41 more
Journal ArticleDOI
Gantenerumab in‐depth outcomes: Results of the DIAN‐TU prevention trial of solanezumab and gantenerumab in dominantly inherited AD
Stephen Salloway,Randall J. Bateman,Andrew J. Aschenbrenner,Tammie L.S. Benzinger,David B. Clifford,Kelley Coalier,Carlos Cruchaga,Anne M. Fagan,Martin R. Farlow,Alison Goate,Brian A. Gordon,Jason Hassenstab,Clifford R. Jack,Robert A. Koeppe,Eric McDade,Susan Mills,John C. Morris,Anna Santacruz,Peter J. Snyder,Guoqiao Wang,Chengjie Xiong,B. Joy Snider,Catherine J. Mummery,Ghulam M. Surti,Didier Hannequin,David Wallon,Sarah B. Berman,James J. Lah,Ivonne Z. Jimenez-Velazquez,Erik D. Roberson,Christopher H. van Dyck,Lawrence S. Honig,Raquel Sánchez-Valle,William S. Brooks,Serge Gauthier,Colin L. Masters,Doug R. Galasko,Jared R. Brosch,Ging-Yuek Robin Hsiung,Suman Jayadev,Maïté Formaglio,Mario Masellis,Roger Clarnette,Jérémie Pariente,Bruno Dubois,Florence Pasquier,Monika Baudler,Paul Delmar,Rachelle S. Doody,Paulo Fontoura,Geoffrey A. Kerchner,Dian‐Tu Study Team +51 more
Journal ArticleDOI
Presymptomatic Alzheimer's disease in the Dominantly Inherited Alzheimer's Network (DIAN)
Randall J. Bateman,Tammie L.S. Benzinger,Nigel J. Cairns,Anne M. Fagan,Alison Goate,Daniel S. Marcus,Martha Storandt,Chengjie Xiong,Virginia Buckles,David M. Holtzman,Krista L. Moulder,Angela Oliver,Anna Santacruz,Nick C. Fox,Bernardino Ghetti,William E. Klunk,Ralph N. Martins,Colin L. Masters,Richard Mayeux,John M. Ringman,Martin N. Rossor,Peter R. Schofield,Reisa A. Sperling,Stephen Salloway,John C. Morris +24 more
TL;DR: A network of scientists and clinicians from around the world are involved in the development and implementation of IC-PL-01, a novel approach to genome-wide dissection of Huntington’s disease.
Journal ArticleDOI
The dominantly inherited alzheimer network trials unit
Randall J. Bateman,Tammie L.S. Benzinger,Scott Berry,David B. Clifford,Anne M. Fagan,Cynthia Duggan,Kathleen Fanning,Alison Goate,Jason Hassenstab,Eric McDade,Susan Mills,John C. Morris,Stephen Salloway,Martin R. Farlow,Anna Santacruz,Guoqiao Wang,Chengjie Xiong +16 more
Journal ArticleDOI
Overview of dominantly inherited AD and top-line DIAN-TU results of solanezumab and gantenerumab
Randall J. Bateman,Andrew J. Aschenbrenner,Tammie L.S. Benzinger,David B. Clifford,Kelley Coalier,Carlos Cruchaga,Anne M. Fagan,Martin R. Farlow,Alison Goate,Brian A. Gordon,Jason Hassenstab,Clifford R. Jack,Robert A. Koeppe,Eric McDade,Susan Mills,John C. Morris,Stephen Salloway,Anna Santacruz,Peter J. Snyder,Guoqiao Wang,Chengjie Xiong,B. Joy Snider,Catherine J. Mummery,Ghulam M. Surti,Didier Hannequin,David Wallon,Sarah B. Berman,James J. Lah,Ivonne Z. Jimenez-Velazquez,Erik D. Roberson,Christopher H. Dyck,Lawrence S. Honig,Raquel Sánchez-Valle,William S. Brooks,Serge Gauthier,Colin L. Masters,Doug R. Galasko,Jared R. Brosch,Ging-Yuek Robin Hsiung,Suman Jayadev,Maïté Formaglio,Mario Masellis,Roger Clarnette,Jérémie Pariente,Bruno Dubois,Florence Pasquier,Scott W. Andersen,Karen C. Holdridge,Mark A. Mintun,John R. Sims,Roy Yaari,Monika Baudler,Paul Delmar,Rachelle S. Doody,Paulo Fontoura,Geoffrey A. Kerchner +55 more
TL;DR: The DIAN‐TU scientific development, implementation of the first AD prevention trial, trial challenges and opportunities, including dose escalation, and top‐line results will be presented.